Biotech industry wins some concessions on GMO rules

The Government has rejected assertions in a report by the House of Lords Select Committee on Science and Technology that excessive regulation has placed the UK's biotechnology industry at a competitive disadvantage. But its response shows that an increasing number of deregulatory moves are now in place or in the pipeline.1

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: report@ends.co.uk

Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content

Register

Subscribe

Prices on request

  • Full access to endsreport.com for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits